Pathogenesis and treatment of aplastic anemia
Hematología (B. Aires)
;
2(2): 63-67, mayo-ago. 1998. tab
Article
Dans Anglais
| LILACS
| ID: lil-341367
RESUMO
Aplastic anemia is a group of hematologic disorders characterized by peripheral blood pancytopenia and a bypocellular bone marrow. Hematopoietic stem cells are decreased and the residual cells are often functionally defective. A preponderance of evidence suggests that acquired aplastic anemia is inmunologically mediated activated T-lymphocytes produce increased quantities of gamma interferon and tumor necrosis factor wich result un suppression of hematopoiesis. Choice of initial treatment for apatient with aplastic anemia depends upon a complex interaction between patient age, disease severity and the availability of a bone marrow dono. Patients with mild disease may be treated with observation, androgens, colony stimulating factors or inmunossupression or bone marrow trnasplantation are indicated. As our knowledge of the pathogenesis of aplastic anemia improves, more effective, less taxic treatment should become available.
Recherche sur Google
Indice:
LILAS (Amériques)
Sujet Principal:
Anémie aplasique
Type d'étude:
Etude d'étiologie
langue:
Anglais
Texte intégral:
Hematología (B. Aires)
Thème du journal:
Hématologie
Année:
1998
Type:
Article
Pays d'affiliation:
Antilles néerlandaises
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS